ID

39972

Descripción

Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration

Palabras clave

  1. 6/3/20 6/3/20 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

6 de marzo de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055

Week 28 - Eye Drop Administration; Treatment Preference Questionnaire

Treatment Preference Questionnaire
Descripción

Treatment Preference Questionnaire

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0558295
UMLS CUI-3
C0034394
Date of Assessment
Descripción

Date of Assessment

Tipo de datos

date

Alias
UMLS CUI [1]
C2985720
Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?
Descripción

Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?

Tipo de datos

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C1272700
UMLS CUI [2,2]
C0087111
UMLS CUI [3]
C0558295
Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?
Descripción

Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?

Tipo de datos

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C1331418
UMLS CUI [2,2]
C0087111
UMLS CUI [3]
C0030193
UMLS CUI [4]
C2364135
UMLS CUI [5]
C1706307
UMLS CUI [6]
C4061283
UMLS CUI [7,1]
C0087111
UMLS CUI [7,2]
C0558295
Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?
Descripción

Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?

Tipo de datos

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C1527305
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0004083
UMLS CUI [3]
C0027769
UMLS CUI [4]
C4054984
UMLS CUI [5]
C0003467
UMLS CUI [6]
C0700361
UMLS CUI [7,1]
C0087111
UMLS CUI [7,2]
C0558295
Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?
Descripción

Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?

Tipo de datos

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2]
C4049986
UMLS CUI [3]
C0871707
UMLS CUI [4,1]
C0087111
UMLS CUI [4,2]
C0558295
Question 5a. If you could only have one treatment, which would you choose?
Descripción

Question 5a. If you could only have one treatment, which would you choose?

Tipo de datos

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1707391
Question 5b. What is the single most important reason for your choice?
Descripción

Question 5b. What is the single most important reason for your choice?

Tipo de datos

text

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C0392360
UMLS CUI [2,2]
C1707391
Eye Drop Administration
Descripción

Eye Drop Administration

Alias
UMLS CUI-1
C0015399
UMLS CUI-2
C1533734
Who has been primarily responsible for administering the medication (eye drops) over the study?
Descripción

Who has been primarily responsible for administering the medication (eye drops) over the study?

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0015399
UMLS CUI [1,2]
C1533734
UMLS CUI [1,3]
C0678341
UMLS CUI [1,4]
C0008976
UMLS CUI [1,5]
C0347984
If other person is responsible for administering the medication, specify
Descripción

If other person is responsible for administering the medication, specify

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0015399
UMLS CUI [1,2]
C1533734
UMLS CUI [1,3]
C0678341
UMLS CUI [1,4]
C0205394
UMLS CUI [1,5]
C2348235

Similar models

Week 28 - Eye Drop Administration; Treatment Preference Questionnaire

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Treatment Preference Questionnaire
C0087111 (UMLS CUI-1)
C0558295 (UMLS CUI-2)
C0034394 (UMLS CUI-3)
Date of Assessment
Item
Date of Assessment
date
C2985720 (UMLS CUI [1])
Item
Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?
integer
C1522634 (UMLS CUI [1])
C1272700 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0558295 (UMLS CUI [3])
Code List
Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?
CL Item
I prefer intravitreal injections (1)
CL Item
I prefer eye drops (2)
CL Item
I have no preference (3)
Item
Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?
integer
C1522634 (UMLS CUI [1])
C1331418 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0030193 (UMLS CUI [3])
C2364135 (UMLS CUI [4])
C1706307 (UMLS CUI [5])
C4061283 (UMLS CUI [6])
C0087111 (UMLS CUI [7,1])
C0558295 (UMLS CUI [7,2])
Code List
Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?
CL Item
I prefer intravitreal injections (1)
CL Item
I prefer eye drops (2)
CL Item
I have no preference (3)
Item
Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?
integer
C1522634 (UMLS CUI [1])
C1527305 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0004083 (UMLS CUI [2,3])
C0027769 (UMLS CUI [3])
C4054984 (UMLS CUI [4])
C0003467 (UMLS CUI [5])
C0700361 (UMLS CUI [6])
C0087111 (UMLS CUI [7,1])
C0558295 (UMLS CUI [7,2])
Code List
Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?
CL Item
I prefer intravitreal injections (1)
CL Item
I prefer eye drops (2)
CL Item
I have no preference (3)
Item
Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?
integer
C1522634 (UMLS CUI [1])
C4049986 (UMLS CUI [2])
C0871707 (UMLS CUI [3])
C0087111 (UMLS CUI [4,1])
C0558295 (UMLS CUI [4,2])
Code List
Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?
CL Item
I prefer intravitreal injections (1)
CL Item
I prefer eye drops (2)
CL Item
I have no preference (3)
Item
Question 5a. If you could only have one treatment, which would you choose?
integer
C1522634 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C1707391 (UMLS CUI [2,2])
Code List
Question 5a. If you could only have one treatment, which would you choose?
CL Item
Intravitreal injections (4)
CL Item
Eye drops (5)
Question 5b. What is the single most important reason for your choice?
Item
Question 5b. What is the single most important reason for your choice?
text
C1522634 (UMLS CUI [1])
C0392360 (UMLS CUI [2,1])
C1707391 (UMLS CUI [2,2])
Item Group
Eye Drop Administration
C0015399 (UMLS CUI-1)
C1533734 (UMLS CUI-2)
Item
Who has been primarily responsible for administering the medication (eye drops) over the study?
text
C0015399 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C0678341 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0347984 (UMLS CUI [1,5])
Code List
Who has been primarily responsible for administering the medication (eye drops) over the study?
CL Item
Caregiver (or equivalent) (1)
CL Item
Subject self-administers (2)
CL Item
Both subject and caregiver (3)
CL Item
Other, specify (OT)
If other person is responsible for administering the medication, specify
Item
If other person is responsible for administering the medication, specify
text
C0015399 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C0678341 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial